切换至 "中华医学电子期刊资源库"

中华临床医师杂志(电子版) ›› 2026, Vol. 20 ›› Issue (06) : 415 -423. doi: 10.3877/cma.j.issn.1674-0785.2026.06.002

临床研究

GerdQ量表在高海拔地区胃食管反流病中的诊断效能及质子泵抑制剂治疗效果的影响因素分析
路源1, 姜超2,†(), 李晓峰1, 杨帅通1   
  1. 1 810000 西宁,青海大学附属医院普通外科三科
    2 810000 西宁,青海大学附属医院肝胆胰二科
  • 收稿日期:2026-05-15 出版日期:2026-06-30
  • 通信作者: 姜超
  • 基金资助:
    青海大学附属医院中青年科研基金项目(ASRF-2024-YB-11)

Application of the gastroesophageal reflux disease questionnaire in patients with gastroesophageal reflux disease at high altitude

Yuan Lu1, Chao Jiang2,†(), Xiaofeng Li1, Shuaitong Yang1   

  1. 1 The Third Department of General Surgery, The Affiliated Hospital of Qinghai University, Xining 810000, China
    2 The Second Department of Hepatobiliary and Pancreatic Surgery, The Affiliated Hospital of Qinghai University, Xining 810000, China
  • Received:2026-05-15 Published:2026-06-30
  • Corresponding author: Chao Jiang
引用本文:

路源, 姜超, 李晓峰, 杨帅通. GerdQ量表在高海拔地区胃食管反流病中的诊断效能及质子泵抑制剂治疗效果的影响因素分析[J/OL]. 中华临床医师杂志(电子版), 2026, 20(06): 415-423.

Yuan Lu, Chao Jiang, Xiaofeng Li, Shuaitong Yang. Application of the gastroesophageal reflux disease questionnaire in patients with gastroesophageal reflux disease at high altitude[J/OL]. Chinese Journal of Clinicians(Electronic Edition), 2026, 20(06): 415-423.

目的

评估GerdQ量表在高海拔地区胃食管反流病(GERD)患者中的诊断效能,并分析影响质子泵抑制剂(PPI)治疗效果的因素。

方法

回顾性分析2024年7月至2025年7月于青海大学附属医院就诊的560例疑似GERD患者。以胃镜检查为一线诊断,内镜阴性者行PPI试验(艾司奥美拉唑40 mg/d,疗程14 d)作为补充确诊手段,将患者分为GERD组(n=469)和非GERD组(n=91)。所有患者均完成治疗前后GerdQ问卷调查。采用ROC曲线评估GerdQ的诊断效能。根据治疗后4条目GerdQ评分,将GERD患者分为治疗有效组(n=312)和无效组(n=157),采用多因素Logistic回归分析影响疗效的独立危险因素,并构建列线图预测模型。

结果

GERD组治疗前GerdQ总分(9.57±2.26)显著高于非GERD组(5.64±2.25),差值为3.93(95%CI:3.42~4.44),P<0.001。GerdQ诊断GERD的最佳截断值为≥8分,AUC为0.893(95%CI:0.862~0.924),敏感度89.1%(95%CI:85.8%~91.9%),特异度76.9%(95%CI:66.9%~85.0%)。PPI治疗后,157例(33.5%)患者疗效不佳。多因素Logistic回归分析显示,BMI≥25 kg/m2(OR=2.03,95%CI:1.33~3.09)、吸烟/饮酒史(OR=3.05,95%CI:1.99~4.68)、基线GerdQ≥10分(OR=2.54,95%CI:1.67~3.86)及高风险职业(牧民、司机,OR=2.05,95%CI:1.12~3.76)是PPI治疗失败的独立危险因素(均P<0.05)。基于上述因素构建的列线图模型,C-index为0.730(95%CI:0.681~0.779),经Bootstrap 1000次内部验证,C-index为0.724,校准斜率为0.972,平均绝对误差为0.074。

结论

GerdQ量表在高海拔地区对GERD具有良好的诊断效能(AUC=0.893),敏感度高,适用于早期筛查和基层医疗。PPI治疗效果受多重因素影响,BMI、生活习惯、症状严重程度及职业类型是独立预测因素。基于危险因素构建的列线图模型(C-index=0.730)具有良好的区分度和校准度,有助于早期识别PPI治疗高风险人群,实现个体化精准治疗。

Objective

To evaluate the diagnostic efficacy of the Gastroesophageal Reflux Disease Questionnaire (GerdQ) in patients with gastroesophageal reflux disease (GERD) at high altitude, and to identify factors influencing the therapeutic effect of proton pump inhibitors (PPIs).

Methods

A retrospective study was conducted on 560 patients with suspected GERD at the Affiliated Hospital of Qinghai University from July 2024 to July 2025. Diagnosis was established primarily by upper gastrointestinal endoscopy, with a PPI test (esomeprazole 40 mg/d for 14 days) reserved for endoscopy-negative cases. Patients were classified into a GERD group (n=469) and a non-GERD group (n=91) based on diagnostic findings. All patients completed the GerdQ before and after treatment. ROC curve analysis was performed to evaluate diagnostic performance. GERD patients were further divided into a response group (n=312) and a non-response group (n=157) based on the post-treatment 4-item GerdQ score. Multivariate Logistic regression was used to identify independent risk factors for treatment failure, and a nomogram prediction model was constructed.

Results

The pretreatment GerdQ score was significantly higher in the GERD group than in the non-GERD group (9.57±2.26 vs 5.64±2.25; mean difference 3.93, 95%CI: 3.42~4.44; P<0.001). The optimal cutoff value for GerdQ in diagnosing GERD was ≥ 8, yielding an AUC of 0.893 (95%CI: 0.862~0.924), sensitivity of 89.1% (95%CI: 85.8%~91.9%), and specificity of 76.9% (95%CI: 66.9%~85.0%). After PPI treatment, 157 patients (33.5%) showed poor response. Multivariate Logistic regression analysis identified BMI≥25 kg/m2 (OR=2.03, 95%CI: 1.33~3.09), smoking/alcohol consumption (OR=3.05, 95%CI: 1.99~4.68), baseline GerdQ score ≥10 (OR=2.54, 95%CI: 1.67~3.86), and high-risk occupations (herdsmen, drivers; OR=2.05, 95%CI: 1.12~3.76) as independent risk factors for PPI treatment failure (all P<0.05). The nomogram model incorporating these factors demonstrated good predictive performance (C-index=0.730, 95%CI: 0.681~0.779). Internal validation using bootstrap with 1000 resamples yielded a C-index of 0.724, a calibration slope of 0.972, and a mean absolute error of 0.074.

Conclusion

The GerdQ demonstrates excellent diagnostic efficacy for GERD in high-altitude populations (AUC=0.893) with high sensitivity, supporting its use in early screening and primary care. PPI response is influenced by multiple factors, with BMI, lifestyle habits, symptom severity, and occupation type serving as independent predictors. The nomogram model (C-index=0.730) with satisfactory discrimination and calibration facilitates early identification of patients at high risk for PPI treatment failure, enabling individualized precise treatment.

表1 2组患者基线资料比较
表2 2组患者治疗前GerdQ评分比较(
±s)
图1 GerdQ量表诊断GERD的ROC曲线 注:GERD为胃食管反流病
图2 GERD患者PPI治疗前后GerdQ评分分布。图a为配对线图;图b为箱线图;图c为评分下降直方图
表3 治疗有效组与治疗无效组基线资料
表4 PPI治疗失败危险因素的多因素Logistic回归分析
图3 PPI治疗失败危险因素的森林图 注:PPI为质子泵抑制剂
图4 预测治疗失败列线图
图5 列线图模型校准曲线
1
Fass R, Boeckxstaens GE, El-Serag H, et al. Gastro-oesophageal reflux disease [J]. Nat Rev Dis Primers, 2021, 7(1): 55.
2
Sharma P, Yadlapati R. Pathophysiology and treatment options for gastroesophageal reflux disease: looking beyond acid [J]. Ann N Y Acad Sci, 2021, 1486(1): 3-14.
3
El-Serag HB, Sweet S, Winchester CC, et al. Update on the epidemiology of gastro-oesophageal reflux disease: a systematic review [J]. Gut, 2014, 63(6): 871-880.
4
张玲, 邹多武. 胃食管反流病的流行病学及危险因素 [J].临床荟萃, 2017, 32(1): 1-4.
5
Mikami DJ, Murayama KM. Physiology and pathogenesis of gastroesophageal reflux disease[J]. Surg Clin North Am, 2015, 95(3): 515-525.
6
Zhang M, Hou ZK, Huang ZB, et al. Dietary and lifestyle factors related to gastroesophageal reflux disease: a systematic review [J]. Ther Clin Risk Manag, 2021, 17: 305-323.
7
Taraszewska A. Risk factors for gastroesophageal reflux disease symptoms related to lifestyle and diet [J]. Rocz Panstw Zakl Hig, 2021, 72(1): 21-28.
8
Zhou C, Li M, Liu L, et al. Food consumption and dietary patterns of local adults living on the Tibetan plateau: results from 14 countries along the Yarlung Tsangpo River [J]. Nutrients, 2021, 13(7): 2444.
9
Wu XY, Hu C, Wong KKF, et al. Gastrointestinal motility disorders at high altitude: a systematic review [J]. High Alt Med Biol, 2020, 21(3): 214-225.
10
Li M, Zhao F, Zhang X, et al. Prevalence and risk factors of gastroesophageal reflux disease in Qinghai plateau: a cross-sectional study [J]. J Dig Dis, 2023, 24(5): 372-380.
11
Zhang H, Gao W, Wang L, et al. A population-based study on prevalence and risk factors of gastroesophageal reflux disease in the Xizang Autonomous Region, China [J]. PeerJ, 2019, 7: e6491.
12
Kumar S, Sharma S, Norboo T, et al. Population based study to assess prevalence and risk factors of gastroesophageal reflux disease in a high altitude area [J]. Indian J Gastroenterol, 2011, 30(3): 135-143.
13
Jones R, Junghard O, Dent J, et al. Development of the GerdQ, a tool for the diagnosis and management of gastro-oesophageal reflux disease in primary care [J]. Aliment Pharmacol Ther, 2009, 30(10): 1030-1038.
14
Simadibrata DM, Ngadiono E, Sinuraya FAG, et al. Diagnostic accuracy of gastroesophageal reflux disease questionnaire for gastroesophageal reflux disease: a systematic review and meta-analysis [J]. Neurogastroenterol Motil, 2023, 35(12): e14619.
15
AbuDujain NM, Batais MA, Muqresh MA, et al. Translation, cultural adaptation, and evaluation of the psychometric properties of the Arabic Gastroesophageal Reflux Disease Questionnaire (Ar-GerdQ) [J]. Saudi J Gastroenterol, 2024, 30(6): 369-375.
16
Suzuki H, Matsuzaki J, Okada S, et al. Validation of the GerdQ questionnaire for the management of gastro-oesophageal reflux disease in Japan [J]. United European Gastroenterol J, 2013, 1(3): 175-183.
17
Gong EJ, Jung KW, Min YW, et al. Validation of the Korean Version of the gastroesophageal reflux disease questionnaire for the diagnosis of gastroesophageal reflux disease [J]. J Neurogastroenterol Motil, 2019, 25(1): 91-99.
18
Vadivelu S, Ma ZF, Ong EW, et al. Clinical validity and reliability of the Malay language translations of gastroesophageal reflux disease questionnaire and quality of life in reflux and dyspepsia questionnaire in a primary care setting [J]. Dig Dis, 2019, 37(2): 100-107.
19
Chapelle N, Ben Ghezala I, Barkun A, et al. The pharmacotherapeutic management of gastroesophageal reflux disease (GERD) [J]. Expert Opin Pharmacother, 2021, 22(2): 219-227.
20
Yadlapati R, Gyawali CP, Pandolfino JE; CGIT GERD consensus conference participants. AGA clinical practice update on the personalized approach to the evaluation and management of GERD: expert review [J]. Clin Gastroenterol Hepatol, 2022, 20(5): 984-994.e1.
21
El-Serag HB, Thrift AP. Obesity and gastroesophageal reflux disease[M]. In: Richter JE, Castell DO, Katzka DA, et al, eds. The Esophagus. 5th ed. Wiley-Blackwell, 2021: Chapter 36.
22
Fass R. Symptom assessment tools for gastroesophageal reflux disease (GERD) treatment [J]. J Clin Gastroenterol, 2007, 41(5): 437-444.
23
Zhang M, Liang M, Chen S, et al. Novel physiologic nomogram discriminates symptom outcome in patients with erosive esophagitis [J]. Esophagus, 2021, 18(2): 407-415.
24
Jin L, Huang XK, Gao ZY, et al. Development and validation of a novel nomogram to predict worsening of gastroesophageal reflux symptoms after laparoscopic sleeve gastrectomy using Lasso-logistic regression [J]. Sci Rep, 2024, 14(1): 25427.
25
Cao H, Yin H, Li L, et al. Low pillow height is associated with LPR among patients with GERD: a retrospective single-center study [J]. BMC Gastroenterol, 2025, 25(1): 778.
26
Lundell LR, Dent J, Bennett JR, et al. Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification [J]. Gut, 1999, 45(2): 172-180.
27
Ghoneim S, Wang J, El Hage Chehade N, et al. Diagnostic accuracy of the proton pump inhibitor test in gastroesophageal reflux disease and noncardiac chest pain: a systematic review and meta-analysis [J]. J Clin Gastroenterol, 2023, 57(4): 380-388.
28
Hurr TJ. The six-question gastroesophageal reflux disease questionnaire (GerdQ) cannot accurately quantify reflux and reflux-associated symptoms frequency [J]. Gastroenterol Rep (Oxf), 2022, 10: goac043.
29
Riley RD, Ensor J, Snell KIE, et al. Calculating the sample size required for developing a clinical prediction model [J]. BMJ, 2020, 368: m441.
30
Tack J, Talley NJ, Camilleri M, et al. Functional gastroduodenal disorders [J]. Gastroenterology, 2006, 130(5): 1466-1479.
31
Kuo CH, Wu LL, Chen HP, et al. Direct effects of alcohol on gut-epithelial barrier: unraveling the disruption of physical and chemical barrier of the gut-epithelial barrier that compromises the host-microbiota interface upon alcohol exposure [J]. J Gastroenterol Hepatol, 2024, 39(7): 1247-1255.
32
Elliott JA, Reynolds JV. Visceral obesity, metabolic syndrome, and esophageal adenocarcinoma [J]. Front Oncol, 2021, 11: 627270.
[1] 邬明嫄, 李婷婷, 鲜欣欣, 罗朝阳, 杨青, 卢漫. 基于超微血流成像血管指数的列线图模型诊断肢端黑色素瘤引流区域淋巴结的价值[J/OL]. 中华医学超声杂志(电子版), 2026, 23(04): 276-282.
[2] 周文考, 张佳坡, 黄培培, 潘艺梅, 朱琳, 李诗睿, 孙慧敏. 多种机器学习算法比较下急性左心衰竭患者住院期间死亡风险预测模型的构建与外部验证[J/OL]. 中华危重症医学杂志(电子版), 2026, 19(03): 198-207.
[3] 蔡洁琛, 余晓宁, 谢健琦. 根尖周炎根管治疗疗效列线图预测模型的构建及效能验证[J/OL]. 中华口腔医学研究杂志(电子版), 2026, 20(05): 404-409.
[4] 李琳, 庞乐, 潘霞, 朱磊, 王桂子, 刘梅. 汉中社区老年人口腔衰弱与躯体衰弱的横断面关联分析及风险评估模型构建[J/OL]. 中华口腔医学研究杂志(电子版), 2026, 20(03): 217-224.
[5] 江伟东, 陈博. 早发性可切除胃癌的临床病理特征及预后列线图模型的建立[J/OL]. 中华普通外科学文献(电子版), 2026, 20(04): 230-237.
[6] 罗文勇, 黄文龙, 阮沁桐, 蔡莹, 王欣, 吴柱国, 王利玲, 于海兵. 甲状腺癌术后并发低钙血症的发病风险预测模型构建[J/OL]. 中华普通外科学文献(电子版), 2026, 20(04): 257-264.
[7] 夏明宇, 刘光昊, 孙倩男, 刘宾, 王道荣. 基于炎症与营养指标的早发型直肠癌患者预后列线图的构建与验证[J/OL]. 中华普外科手术学杂志(电子版), 2026, 20(05): 468-473.
[8] 李若隐, 罗义, 张雪琳, 雷李凤, 李思丽. MDSCs相关基因在乳腺癌中表达特征分析与风险预测模型构建[J/OL]. 中华普外科手术学杂志(电子版), 2026, 20(04): 366-373.
[9] 芮梓轩, 费博, 喻春钊, 苟缙, 刘天宇. 抗反流手术患者食管裂孔疝术前检出情况及其相关因素分析[J/OL]. 中华疝和腹壁外科杂志(电子版), 2026, 20(05): 506-512.
[10] 刘兰英, 王鸿, 刘振, 常彦杰, 张建磊, 杜雪梅. 基于NLR/ALB构建的列线图预测模型在慢性阻塞性肺疾病急性加重期患者短期预后中的应用价值[J/OL]. 中华肺部疾病杂志(电子版), 2026, 19(05): 826-833.
[11] 王平, 郝天骄, 陈兴宇, 翟俊, 朱文伟, 陈季松. 急性坏疽性胆囊炎临床风险预测模型的建立与验证[J/OL]. 中华肝脏外科手术学电子杂志, 2026, 15(05): 760-767.
[12] 陈志坚, 俞建达, 林泽润, 林宏焕, 易长昱, 池小斌, 吕立志, 陈永标. 基于术前影像肿瘤负荷评分的模型对单发肝细胞癌微血管侵犯的预测价值[J/OL]. 中华肝脏外科手术学电子杂志, 2026, 15(03): 379-385.
[13] 曹佩佩, 叶峰, 丁静. 食管肿瘤内镜黏膜下剥离术后电凝综合征列线图预测模型的构建[J/OL]. 中华消化病与影像杂志(电子版), 2026, 16(05): 415-421.
[14] 郑月, 刘译阳, 袁梦晨, 尤亚茹, 李莉明, 张哲, 陈俣菘, 范松梅, 高剑波. 基于增强CT的列线图术前辅助性预测胃癌患者的EB病毒状态[J/OL]. 中华消化病与影像杂志(电子版), 2026, 16(05): 422-429.
[15] 宋宏伟, 张宇, 张珊珊. 四逆散联合西医治疗老年难治性胃食管反流病肝胃不和证患者的疗效及对细胞因子的影响研究[J/OL]. 中华消化病与影像杂志(电子版), 2026, 16(05): 452-456.
阅读次数
全文


摘要


AI
小
编
AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?